Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

The three major stock indices closed higher on Tuesday, aided by energy stocks, while investors saw reason for optimism for a ...

February is Cancer Prevention Awareness Month. According to the West Virginia Department of Health and Human Resources, about ...

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...

Executives pulled back on a 2030 sales target of $11 billion as demand for the HPV shot shrinks amid China market turmoil.

An experimental therapeutic human papillomavirus (HPV) vaccine showed promise in inducing regression of precancerous cervical lesions as well as viral clearance in patients with cervical ...

Kennedy has in particular focused on Gardasil, the HPV vaccine. A lawyer by trade, he has helped facilitate hundreds of potential lawsuits aimed at pharmaceutical company Merck, which manufactures ...

However, a significant tool in the fight against this preventable disease is the Human Papillomavirus (HPV) vaccine. This vaccine, which is both safe and effective, offers a clear path to reducing ...

Japan approved the use of the HPV vaccine in 2009. In April 2013, girls between the sixth grade of elementary school and the first year of high school, aged between 11 to 16, became eligible for ...

Merck’s recent earnings call revealed that although the company generated worldwide sales of $64.2 billion—an 7% increase over 2023—the company will be temporarily suspending Gardasil shipments to ...

Houston Weather Forecast: After a warm and muggy week, several rain and cold fronts are on the way Suspect arrested after University of Houston student was sexually assaulted in parking garage ...